BCL2 and glioma: Treatment with let-7f decreases proliferation while increasing G1 phase cell count and apoptosis of glioma cells by decreasing CCND1, CCNE1, and Bcl-2 expression, increasing P21, P27, and Bax expression, and increasing caspase-3 activity [68].